Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in IPHA — Innate Pharma SA

CIK 1115418 BOSTON, MA
Back to IPHA Full portfolio

Position in IPHA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,682
+$2,623 QoQ
Shares Held
4,719
-0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 10 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IPHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. IPHA ranks #312 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in IPHA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,682 4,719
2026-03-31 $6,059 4,734
2025-12-31 $9,107 5,204
2025-09-30 $907 470
2025-06-30 $853 470
2025-03-31 $1,201 675
2024-12-31 $1,242 675
2024-09-30 $469 205
2024-06-30 $397 205
2024-03-31 $590 205
2023-12-31 $574 205
2023-09-30 $518 205
2023-06-30 $630 205